Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Κατάταξη σε μετοχές #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Τιμή μετοχής
$154.51
Κεφαλαιοποίηση
$55.98B
Αλλαγή (1 ημέρα)
-1.82%
Αλλαγή (1 έτος)
-32.08%
Χώρα
US
Εμπόριο Becton, Dickinson and Company (BDX)

Κατηγορία

Κέρδη για την Becton, Dickinson and Company (BDX)
Κέρδη τον Dec 2025 TTM: $2.06B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Becton, Dickinson and Company, τα τρέχοντα κέρδη της εταιρείας είναι $2.06B. Το 2024, η εταιρεία παρουσίασε κέρδη $2.01B, αύξηση σε σχέση με των κερδών του 2023 που ήταν $1.66B. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Becton, Dickinson and Company από 2000 έως 2026
Κέρδη στο τέλος κάθε έτους
Έτος Κέρδη Αλλαγή
2026 (TTM) $2.06B 9.62%
2025 $1.88B -6.13%
2024 $2.01B 20.64%
2023 $1.66B -6.79%
2022 $1.78B 5.38%
2021 $1.69B 308.70%
2020 $414.00M -64.80%
2019 $1.18B 0.26%
2018 $1.17B 20.18%
2017 $976.00M -9.12%
2016 $1.07B 45.33%
2015 $739.00M -51.45%
2014 $1.52B 30.64%
2013 $1.17B -20.86%
2012 $1.47B -9.02%
2011 $1.62B 3.27%
2010 $1.57B -0.75%
2009 $1.58B 2.61%
2008 $1.54B 27.78%
2007 $1.20B 6.93%
2006 $1.13B 12.05%
2005 $1.00B 33.47%
2004 $752.87M 4.28%
2003 $721.96M 15.06%
2002 $627.47M 8.79%
2001 $576.75M 10.93%
2000 $519.93M 0.00%
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
Εταιρεία Κέρδη Διαφορά Κερδών Χώρα
$3.31B 60.51%
US
$394.38M -80.88%
DE
$2.05B -0.80%
JP
$1.16B -43.77%
CH
$1.82B -11.84%
US